Jim Cramer Says Avoid This Stock: ‘Too Expensive’

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Blackline, Inc. (NASDAQ: BL) was an enterprise software company that was losing money.

On CNBC’s “Mad Money Lightning Round,” Jim Cramer said Blackline, Inc. (NASDAQ:BL) was an enterprise software company that was losing money. “Those are the ones I’m trying to get people to stay away from,” he added.

When asked about Blackstone Inc (NYSE:BX), he said, “Pull the trigger.”

Cramer noted Piedmont Lithium Inc (NASDAQ:PLL) was “much too dangerous. Way too speculative. We’re going to take a pass on that one.”

Don’t forget to check out our premarket coverage here.

When asked about Novo Nordisk A/S (NYSE:NVO), Cramer said, “I want you to switch into Eli Lilly and Co (NYSE:LLY).”

The “Mad Money” host recommended avoiding Bloom Energy Corp (NYSE:BE) as it is “too expensive.”

“This thing has had way too big a move. I cannot get behind it. It’s way too speculative,” Cramer said when asked about Oramed Pharmaceuticals Inc. (NASDAQ:ORMP).

Now Read This: $1.2 Million Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying

Photo: pathdoc via Shutterstock

Total
0
Shares
Related Posts
Read More

Why Alzheimers-Drug Developer Cassava Sciences Stock Is Trending

The top-line results showed no decline in cognition scores in patients with mild Alzheimer's disease who received simufilam continuously for 24 months. "We're fighting Alzheimer's disease by testing simufilam, a new type of drug that has a completely different mechanism of action from monoclonal antibody drug treatments," said Remi Barbier, CEO of Cassava.

SAVA